[Studies of clinical usefulness of new tumor markers of ovarian cancer, CA 54/61 and CA 602--CA 602 assay reagent kit, performance its normal value and correlations with other tumor markers].

@article{Nozawa1992StudiesOC,
  title={[Studies of clinical usefulness of new tumor markers of ovarian cancer, CA 54/61 and CA 602--CA 602 assay reagent kit, performance its normal value and correlations with other tumor markers].},
  author={Shiro Nozawa and Yasuhiro Udagawa and Hiroshi Sasaki and Katsuhide Ito and Kumiko Akiya and Yoshiyasu Terashima and Hiroyoshi Takamizawa and Hisanao Ohkura and Shigeru Fujimoto and Masaji Hashimoto},
  journal={Gan to kagaku ryoho. Cancer & chemotherapy},
  year={1992},
  volume={19 12},
  pages={2085-93}
}
We made a preclinical study of a newly developed tumor maker, CA 602, and its clinical study using serum samples available from 58 institutions located throughout Japan. In the preclinical study, a CA 602 assay kit was investigated for the reproducibility and precision of assay results; and in the clinical study, the kit was investigated for the normal value of the marker, for variations in assay result with age, menstrual cycle and term of pregnancy, and for correlations of assay results with… CONTINUE READING